Impact of low-level pretransplant donor-specific antibodies on outcomes after kidney transplantation.

While low-level DSA should not prevent proceeding with kidney transplantation, it should not be ignored. Future studies are needed to investigate the long-term effects of varying levels of pre-transplant DSA on outcomes.